{"id":867519,"date":"2025-07-08T11:23:05","date_gmt":"2025-07-08T15:23:05","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/rckt-investor-alert-securities-litigation-partner-james-josh-wilson-encourages-investors-who-suffered-losses-exceeding-50000-in-rckt-to-contact-him-directly-to-discuss-their-options\/"},"modified":"2025-07-08T11:23:05","modified_gmt":"2025-07-08T15:23:05","slug":"rckt-investor-alert-securities-litigation-partner-james-josh-wilson-encourages-investors-who-suffered-losses-exceeding-50000-in-rckt-to-contact-him-directly-to-discuss-their-options","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/rckt-investor-alert-securities-litigation-partner-james-josh-wilson-encourages-investors-who-suffered-losses-exceeding-50000-in-rckt-to-contact-him-directly-to-discuss-their-options\/","title":{"rendered":"RCKT INVESTOR ALERT: Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In RCKT To Contact Him Directly To Discuss Their Options"},"content":{"rendered":"<div class=\"xn-newslines\">\n<p class=\"xn-distributor\">PR Newswire<\/p>\n<\/p><\/div>\n<div class=\"xn-content\">\n<p>\n        <b>Faruqi &amp; Faruqi, LLP Securities Litigation Partner <\/b><br \/>\n        <a href=\"https:\/\/c212.net\/c\/link\/?t=0&amp;l=en&amp;o=4463489-1&amp;h=3438676603&amp;u=https%3A%2F%2Fwww.faruqilaw.com%2Fattorney%2F22%2Fjames-m-wilson-jr&amp;a=James+(Josh)+Wilson\" target=\"_blank\" rel=\"nofollow\"><br \/>\n          <b><br \/>\n            <span class=\"xn-person\">James (Josh) Wilson<\/span><br \/>\n          <\/b><br \/>\n        <\/a><br \/>\n        <b>\u00a0Encourages Investors Who Suffered Losses Exceeding <span class=\"xn-money\">$50,000<\/span> In Rocket Pharmaceuticals To Contact Him Directly To Discuss Their Options<\/b>\n      <\/p>\n<p>\n        <b>If you suffered losses exceeding <span class=\"xn-money\">$50,000<\/span> in <\/b><br \/>\n        <a href=\"https:\/\/c212.net\/c\/link\/?t=0&amp;l=en&amp;o=4463489-1&amp;h=4287258970&amp;u=https%3A%2F%2Fwww.faruqilaw.com%2FRCKT&amp;a=Rocket+Pharmaceuticals\" target=\"_blank\" rel=\"nofollow\"><br \/>\n          <b>Rocket Pharmaceuticals<\/b><br \/>\n        <\/a><br \/>\n        <b>\u00a0between <span class=\"xn-chron\">February 27, 2025<\/span> and <span class=\"xn-chron\">May 26, 2025<\/span><\/b>and would like to discuss your legal rights, call Faruqi &amp; Faruqi partner <b><span class=\"xn-person\">Josh Wilson<\/span> directly <\/b>at <b>877-247-4292 <\/b>or <b>212-983-9330<\/b><b>\u00a0(Ext. 1310)<\/b>.<\/p>\n<p class=\"prntac\">\n        <a href=\"https:\/\/c212.net\/c\/link\/?t=0&amp;l=en&amp;o=4463489-1&amp;h=2904137093&amp;u=https%3A%2F%2Fwww.faruqilaw.com%2FRCKT&amp;a=%5BYou+may+also+click+here+for+additional+information%5D\" target=\"_blank\" rel=\"nofollow\"><br \/>\n          <b>[You may also click here for additional information]<\/b><br \/>\n        <\/a>\n      <\/p>\n<p>\n        <span class=\"legendSpanClass\"><br \/>\n          <span class=\"xn-location\">NEW YORK<\/span><br \/>\n        <\/span>, <span class=\"legendSpanClass\"><span class=\"xn-chron\">July 8, 2025<\/span><\/span> \/PRNewswire\/ &#8212; <a href=\"https:\/\/c212.net\/c\/link\/?t=0&amp;l=en&amp;o=4463489-1&amp;h=603325161&amp;u=https%3A%2F%2Fwww.faruqilaw.com%2F&amp;a=Faruqi+%26+Faruqi%2C+LLP\" target=\"_blank\" rel=\"nofollow\">Faruqi &amp; Faruqi, LLP<\/a>, a leading national securities law firm, is investigating potential claims against Rocket Pharmaceuticals, Inc. (&#8220;Rocket&#8221; or the &#8220;Company&#8221;) (NASDAQ: RCKT) and reminds investors of the <b><span class=\"xn-chron\">August 11, 2025<\/span> deadline<\/b> to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company.<\/p>\n<div class=\"PRN_ImbeddedAssetReference\" id=\"DivAssetPlaceHolder1\">\n<p>\n          <a href=\"https:\/\/mma.prnewswire.com\/media\/2457438\/Faruqi_Logo.html\" target=\"_blank\" rel=\"nofollow\"><br \/>\n            <img decoding=\"async\" src=\"https:\/\/mma.prnewswire.com\/media\/2457438\/Faruqi_Logo.jpg\" title=\"Faruqi &amp; Faruqi, LLP (PRNewsfoto\/Faruqi &amp; Faruqi, LLP)\" alt=\"Faruqi &amp; Faruqi, LLP (PRNewsfoto\/Faruqi &amp; Faruqi, LLP)\" \/><br \/>\n          <\/a>\n        <\/p>\n<\/p><\/div>\n<p>Faruqi &amp; Faruqi is a leading national securities law firm with offices in <span class=\"xn-location\">New York<\/span>, <span class=\"xn-location\">Pennsylvania<\/span>, <span class=\"xn-location\">California<\/span> and <span class=\"xn-location\">Georgia<\/span>. The firm has recovered hundreds of millions of dollars for investors since its founding in 1995. See <a href=\"https:\/\/c212.net\/c\/link\/?t=0&amp;l=en&amp;o=4463489-1&amp;h=1031580897&amp;u=https%3A%2F%2Fwww.faruqilaw.com%2F&amp;a=www.faruqilaw.com\" target=\"_blank\" rel=\"nofollow\">www.faruqilaw.com<\/a>.<\/p>\n<p>According to the complaint, defendants provided overwhelmingly positive statements to investors while, at the same time, disseminating materially false and misleading statements and\/or concealing material adverse facts concerning the true state of RP-A501&#8217;s safety and clinical trial protocol; notably, that Rocket knew Serious Adverse Events (SAEs), including death of participants enrolled in the study, were a risk. In particular, Rocket amended the trial&#8217;s protocol to introduce a novel immunomodulatory agent to the pretreatment regimen without providing this critical update to shareholders. Such statements absent these material facts caused Plaintiff and other shareholders to purchase Rocket&#8217;s securities at artificially inflated prices.<\/p>\n<p>On <span class=\"xn-chron\">May 27, 2025<\/span>, Rocket announced that the FDA placed a clinical hold on the RP-A501 Phase 2 pivotal study after at least one patient suffered a Serious Adverse Event (SAE), ultimately, death, while enrolled in the study following a substantive amendment to the protocol that the Company failed to disclose to investors at the time management made the revision. In fact, Rocket stated that, while the patient was dosed in May, the decision to amend the protocol was made &#8220;several months&#8221; earlier. Despite this, Rocket made no attempt to alert investors or the public to the change until after the SAE occurred.<\/p>\n<p>Following this news, the price of Rocket&#8217;s common stock declined dramatically. From a closing market price of <span class=\"xn-money\">$6.27<\/span> per share on <span class=\"xn-chron\">May 23, 2025<\/span>, Rocket&#8217;s stock price fell to <span class=\"xn-money\">$2.33<\/span> per share on <span class=\"xn-chron\">May 27, 2025<\/span>, a decline of about 37% in the span of just a single trading day.<\/p>\n<p>The court-appointed lead plaintiff is the investor with the largest financial interest in the relief sought by the class who is adequate and typical of class members who directs and oversees the litigation on behalf of the putative class. Any member of the putative class may move the Court to serve as lead plaintiff through counsel of their choice, or may choose to do nothing and remain an absent class member. Your ability to share in any recovery is not affected by the decision to serve as a lead plaintiff or not.\u00a0<\/p>\n<p>Faruqi &amp; Faruqi, LLP also encourages anyone with information regarding Rocket&#8217;s conduct to contact the firm, including whistleblowers, former employees, shareholders and others.<\/p>\n<p>To learn more about the <b>Rocket Pharmaceuticals<\/b> class action, go to <a href=\"https:\/\/c212.net\/c\/link\/?t=0&amp;l=en&amp;o=4463489-1&amp;h=3816686533&amp;u=https%3A%2F%2Fwww.faruqilaw.com%2FRCKT&amp;a=www.faruqilaw.com%2FRCKT\" target=\"_blank\" rel=\"nofollow\"><b>www.faruqilaw.com\/RCKT<\/b><\/a>\u00a0or <b>call<\/b>\u00a0Faruqi &amp; Faruqi partner <b><span class=\"xn-person\">Josh Wilson<\/span> directly <\/b>at <b>877-247-4292 <\/b>or <b>212-983-9330<\/b><b>\u00a0(Ext. 1310)<\/b>.<\/p>\n<p>Follow us for updates on <a href=\"https:\/\/c212.net\/c\/link\/?t=0&amp;l=en&amp;o=4463489-1&amp;h=915651834&amp;u=https%3A%2F%2Fwww.linkedin.com%2Fcompany%2Ffaruqi-%26-faruqi-llp%2F&amp;a=LinkedIn\" target=\"_blank\" rel=\"nofollow\">LinkedIn<\/a>, on <a href=\"https:\/\/c212.net\/c\/link\/?t=0&amp;l=en&amp;o=4463489-1&amp;h=1323166154&amp;u=https%3A%2F%2Fx.com%2Ffaruqilaw&amp;a=X\" target=\"_blank\" rel=\"nofollow\">X<\/a>, or on <a href=\"https:\/\/c212.net\/c\/link\/?t=0&amp;l=en&amp;o=4463489-1&amp;h=4244067735&amp;u=https%3A%2F%2Fwww.facebook.com%2FFaruqiLaw%2F&amp;a=Facebook\" target=\"_blank\" rel=\"nofollow\">Facebook<\/a>.<\/p>\n<p>Attorney Advertising. The law firm responsible for this advertisement is Faruqi &amp; Faruqi, LLP (<a href=\"\/Users\/nhalloran\/AppData\/Local\/Microsoft\/Windows\/INetCache\/Content.Outlook\/6J7VE6NH\/www.faruqilaw.com\" target=\"_blank\" rel=\"nofollow\">www.faruqilaw.com<\/a>). Prior results do not guarantee or predict a similar outcome with respect to any future matter. We welcome the opportunity to discuss your particular case. All communications will be treated in a confidential manner.<\/p>\n<div class=\"PRN_ImbeddedAssetReference\" id=\"DivAssetPlaceHolder2\">\n<p>\n          <a href=\"https:\/\/mma.prnewswire.com\/media\/1959220\/Logo_11_30_2022.html\" target=\"_blank\" rel=\"nofollow\"><br \/>\n            <img decoding=\"async\" src=\"https:\/\/mma.prnewswire.com\/media\/1959220\/Logo_11_30_2022.jpg\" title=\"Faruqi &amp; Faruqi Logo (PRNewsfoto\/Faruqi &amp; Faruqi, LLP)\" alt=\"Faruqi &amp; Faruqi Logo (PRNewsfoto\/Faruqi &amp; Faruqi, LLP)\" \/><br \/>\n          <\/a>\n        <\/p>\n<\/p><\/div>\n<p id=\"PURL\">\n        <img loading=\"lazy\" decoding=\"async\" title=\"Cision\" width=\"12\" height=\"12\" alt=\"Cision\" src=\"https:\/\/c212.net\/c\/img\/favicon.png?sn=NY25313&amp;sd=2025-07-08\" \/> View original content to download multimedia:<a id=\"PRNURL\" rel=\"nofollow\" href=\"https:\/\/www.prnewswire.com\/news-releases\/rckt-investor-alert-securities-litigation-partner-james-josh-wilson-encourages-investors-who-suffered-losses-exceeding-50-000-in-rckt-to-contact-him-directly-to-discuss-their-options-302499728.html\" target=\"_blank\">https:\/\/www.prnewswire.com\/news-releases\/rckt-investor-alert-securities-litigation-partner-james-josh-wilson-encourages-investors-who-suffered-losses-exceeding-50-000-in-rckt-to-contact-him-directly-to-discuss-their-options-302499728.html<\/a><\/p>\n<p>SOURCE  Faruqi &amp; Faruqi, LLP<\/p>\n<\/p><\/div>\n<p>    <img decoding=\"async\" alt=\"\" src=\"https:\/\/rt.prnewswire.com\/rt.gif?NewsItemId=NY25313&amp;Transmission_Id=202507081120PR_NEWS_USPR_____NY25313&amp;DateId=20250708\" style=\"border:0px;width:1px;height:1px\" \/><\/p>\n","protected":false},"excerpt":{"rendered":"<p>PR Newswire Faruqi &amp; Faruqi, LLP Securities Litigation Partner James (Josh) Wilson \u00a0Encourages Investors Who Suffered Losses Exceeding $50,000 In Rocket Pharmaceuticals To Contact Him Directly To Discuss Their Options If you suffered losses exceeding $50,000 in Rocket Pharmaceuticals \u00a0between February 27, 2025 and May 26, 2025and would like to discuss your legal rights, call Faruqi &amp; Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330\u00a0(Ext. 1310). [You may also click here for additional information] NEW YORK , July 8, 2025 \/PRNewswire\/ &#8212; Faruqi &amp; Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Rocket Pharmaceuticals, Inc. (&#8220;Rocket&#8221; or the &#8220;Company&#8221;) (NASDAQ: RCKT) and reminds investors of the August 11, 2025 deadline to seek the role &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/rckt-investor-alert-securities-litigation-partner-james-josh-wilson-encourages-investors-who-suffered-losses-exceeding-50000-in-rckt-to-contact-him-directly-to-discuss-their-options\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;RCKT INVESTOR ALERT: Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In RCKT To Contact Him Directly To Discuss Their Options&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-867519","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>RCKT INVESTOR ALERT: Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In RCKT To Contact Him Directly To Discuss Their Options - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/rckt-investor-alert-securities-litigation-partner-james-josh-wilson-encourages-investors-who-suffered-losses-exceeding-50000-in-rckt-to-contact-him-directly-to-discuss-their-options\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"RCKT INVESTOR ALERT: Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In RCKT To Contact Him Directly To Discuss Their Options - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"PR Newswire Faruqi &amp; Faruqi, LLP Securities Litigation Partner James (Josh) Wilson \u00a0Encourages Investors Who Suffered Losses Exceeding $50,000 In Rocket Pharmaceuticals To Contact Him Directly To Discuss Their Options If you suffered losses exceeding $50,000 in Rocket Pharmaceuticals \u00a0between February 27, 2025 and May 26, 2025and would like to discuss your legal rights, call Faruqi &amp; Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330\u00a0(Ext. 1310). [You may also click here for additional information] NEW YORK , July 8, 2025 \/PRNewswire\/ &#8212; Faruqi &amp; Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Rocket Pharmaceuticals, Inc. (&#8220;Rocket&#8221; or the &#8220;Company&#8221;) (NASDAQ: RCKT) and reminds investors of the August 11, 2025 deadline to seek the role &hellip; Continue reading &quot;RCKT INVESTOR ALERT: Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In RCKT To Contact Him Directly To Discuss Their Options&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/rckt-investor-alert-securities-litigation-partner-james-josh-wilson-encourages-investors-who-suffered-losses-exceeding-50000-in-rckt-to-contact-him-directly-to-discuss-their-options\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2025-07-08T15:23:05+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mma.prnewswire.com\/media\/2457438\/Faruqi_Logo.jpg\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/rckt-investor-alert-securities-litigation-partner-james-josh-wilson-encourages-investors-who-suffered-losses-exceeding-50000-in-rckt-to-contact-him-directly-to-discuss-their-options\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/rckt-investor-alert-securities-litigation-partner-james-josh-wilson-encourages-investors-who-suffered-losses-exceeding-50000-in-rckt-to-contact-him-directly-to-discuss-their-options\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"RCKT INVESTOR ALERT: Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In RCKT To Contact Him Directly To Discuss Their Options\",\"datePublished\":\"2025-07-08T15:23:05+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/rckt-investor-alert-securities-litigation-partner-james-josh-wilson-encourages-investors-who-suffered-losses-exceeding-50000-in-rckt-to-contact-him-directly-to-discuss-their-options\\\/\"},\"wordCount\":664,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/rckt-investor-alert-securities-litigation-partner-james-josh-wilson-encourages-investors-who-suffered-losses-exceeding-50000-in-rckt-to-contact-him-directly-to-discuss-their-options\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/2457438\\\/Faruqi_Logo.jpg\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/rckt-investor-alert-securities-litigation-partner-james-josh-wilson-encourages-investors-who-suffered-losses-exceeding-50000-in-rckt-to-contact-him-directly-to-discuss-their-options\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/rckt-investor-alert-securities-litigation-partner-james-josh-wilson-encourages-investors-who-suffered-losses-exceeding-50000-in-rckt-to-contact-him-directly-to-discuss-their-options\\\/\",\"name\":\"RCKT INVESTOR ALERT: Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In RCKT To Contact Him Directly To Discuss Their Options - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/rckt-investor-alert-securities-litigation-partner-james-josh-wilson-encourages-investors-who-suffered-losses-exceeding-50000-in-rckt-to-contact-him-directly-to-discuss-their-options\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/rckt-investor-alert-securities-litigation-partner-james-josh-wilson-encourages-investors-who-suffered-losses-exceeding-50000-in-rckt-to-contact-him-directly-to-discuss-their-options\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/2457438\\\/Faruqi_Logo.jpg\",\"datePublished\":\"2025-07-08T15:23:05+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/rckt-investor-alert-securities-litigation-partner-james-josh-wilson-encourages-investors-who-suffered-losses-exceeding-50000-in-rckt-to-contact-him-directly-to-discuss-their-options\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/rckt-investor-alert-securities-litigation-partner-james-josh-wilson-encourages-investors-who-suffered-losses-exceeding-50000-in-rckt-to-contact-him-directly-to-discuss-their-options\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/rckt-investor-alert-securities-litigation-partner-james-josh-wilson-encourages-investors-who-suffered-losses-exceeding-50000-in-rckt-to-contact-him-directly-to-discuss-their-options\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/2457438\\\/Faruqi_Logo.jpg\",\"contentUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/2457438\\\/Faruqi_Logo.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/rckt-investor-alert-securities-litigation-partner-james-josh-wilson-encourages-investors-who-suffered-losses-exceeding-50000-in-rckt-to-contact-him-directly-to-discuss-their-options\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"RCKT INVESTOR ALERT: Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In RCKT To Contact Him Directly To Discuss Their Options\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"RCKT INVESTOR ALERT: Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In RCKT To Contact Him Directly To Discuss Their Options - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/rckt-investor-alert-securities-litigation-partner-james-josh-wilson-encourages-investors-who-suffered-losses-exceeding-50000-in-rckt-to-contact-him-directly-to-discuss-their-options\/","og_locale":"en_US","og_type":"article","og_title":"RCKT INVESTOR ALERT: Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In RCKT To Contact Him Directly To Discuss Their Options - Market Newsdesk","og_description":"PR Newswire Faruqi &amp; Faruqi, LLP Securities Litigation Partner James (Josh) Wilson \u00a0Encourages Investors Who Suffered Losses Exceeding $50,000 In Rocket Pharmaceuticals To Contact Him Directly To Discuss Their Options If you suffered losses exceeding $50,000 in Rocket Pharmaceuticals \u00a0between February 27, 2025 and May 26, 2025and would like to discuss your legal rights, call Faruqi &amp; Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330\u00a0(Ext. 1310). [You may also click here for additional information] NEW YORK , July 8, 2025 \/PRNewswire\/ &#8212; Faruqi &amp; Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Rocket Pharmaceuticals, Inc. (&#8220;Rocket&#8221; or the &#8220;Company&#8221;) (NASDAQ: RCKT) and reminds investors of the August 11, 2025 deadline to seek the role &hellip; Continue reading \"RCKT INVESTOR ALERT: Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In RCKT To Contact Him Directly To Discuss Their Options\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/rckt-investor-alert-securities-litigation-partner-james-josh-wilson-encourages-investors-who-suffered-losses-exceeding-50000-in-rckt-to-contact-him-directly-to-discuss-their-options\/","og_site_name":"Market Newsdesk","article_published_time":"2025-07-08T15:23:05+00:00","og_image":[{"url":"https:\/\/mma.prnewswire.com\/media\/2457438\/Faruqi_Logo.jpg","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/rckt-investor-alert-securities-litigation-partner-james-josh-wilson-encourages-investors-who-suffered-losses-exceeding-50000-in-rckt-to-contact-him-directly-to-discuss-their-options\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/rckt-investor-alert-securities-litigation-partner-james-josh-wilson-encourages-investors-who-suffered-losses-exceeding-50000-in-rckt-to-contact-him-directly-to-discuss-their-options\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"RCKT INVESTOR ALERT: Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In RCKT To Contact Him Directly To Discuss Their Options","datePublished":"2025-07-08T15:23:05+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/rckt-investor-alert-securities-litigation-partner-james-josh-wilson-encourages-investors-who-suffered-losses-exceeding-50000-in-rckt-to-contact-him-directly-to-discuss-their-options\/"},"wordCount":664,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/rckt-investor-alert-securities-litigation-partner-james-josh-wilson-encourages-investors-who-suffered-losses-exceeding-50000-in-rckt-to-contact-him-directly-to-discuss-their-options\/#primaryimage"},"thumbnailUrl":"https:\/\/mma.prnewswire.com\/media\/2457438\/Faruqi_Logo.jpg","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/rckt-investor-alert-securities-litigation-partner-james-josh-wilson-encourages-investors-who-suffered-losses-exceeding-50000-in-rckt-to-contact-him-directly-to-discuss-their-options\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/rckt-investor-alert-securities-litigation-partner-james-josh-wilson-encourages-investors-who-suffered-losses-exceeding-50000-in-rckt-to-contact-him-directly-to-discuss-their-options\/","name":"RCKT INVESTOR ALERT: Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In RCKT To Contact Him Directly To Discuss Their Options - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/rckt-investor-alert-securities-litigation-partner-james-josh-wilson-encourages-investors-who-suffered-losses-exceeding-50000-in-rckt-to-contact-him-directly-to-discuss-their-options\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/rckt-investor-alert-securities-litigation-partner-james-josh-wilson-encourages-investors-who-suffered-losses-exceeding-50000-in-rckt-to-contact-him-directly-to-discuss-their-options\/#primaryimage"},"thumbnailUrl":"https:\/\/mma.prnewswire.com\/media\/2457438\/Faruqi_Logo.jpg","datePublished":"2025-07-08T15:23:05+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/rckt-investor-alert-securities-litigation-partner-james-josh-wilson-encourages-investors-who-suffered-losses-exceeding-50000-in-rckt-to-contact-him-directly-to-discuss-their-options\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/rckt-investor-alert-securities-litigation-partner-james-josh-wilson-encourages-investors-who-suffered-losses-exceeding-50000-in-rckt-to-contact-him-directly-to-discuss-their-options\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/rckt-investor-alert-securities-litigation-partner-james-josh-wilson-encourages-investors-who-suffered-losses-exceeding-50000-in-rckt-to-contact-him-directly-to-discuss-their-options\/#primaryimage","url":"https:\/\/mma.prnewswire.com\/media\/2457438\/Faruqi_Logo.jpg","contentUrl":"https:\/\/mma.prnewswire.com\/media\/2457438\/Faruqi_Logo.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/rckt-investor-alert-securities-litigation-partner-james-josh-wilson-encourages-investors-who-suffered-losses-exceeding-50000-in-rckt-to-contact-him-directly-to-discuss-their-options\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"RCKT INVESTOR ALERT: Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In RCKT To Contact Him Directly To Discuss Their Options"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/867519","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=867519"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/867519\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=867519"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=867519"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=867519"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}